JP3701000006
JP3701000006
JCR PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 40.319.000.000 | 33.072.000.000 | 21.9% |
| Cost of Revenue | 10.134.000.000 | 10.902.000.000 | 7.0% |
| Gross Profit | 30.185.000.000 | 22.169.000.000 | 36.2% |
| 29.629.000.000 | 28.389.000.000 | 4.4% | |
| Operating Income | 556.000.000 | -6.220.000.000 | 108.9% |
| Pretax Income | 3.224.000.000 | -5.983.000.000 | 153.9% |
| Net Income Common Stockholders | 2.178.000.000 | -4.460.000.000 | 148.8% |
| -- | -- | -- | |
| -- | -- | -- |